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INTRODUCTION 
 Abortion is the termination of pregnancy before the fetus has attained the 
stage of viability. This was originally fixed at 28 weeks, which corresponds to a 
fetal wt of 1000gm. With expert neonatal care, this limit has been brought 
down to 20 weeks of pregnancy, corresponding to fetal wt of 500gm in 
developed countries. 
 Abortion may be spontaneous or induced. Induced abortions are 
deliberately caused and these may be legal or illegal. 
 Unsafe abortions are those, which are performed by untrained persons 
and/or improperly equipped institution and are more likely to result in maternal 
morbidity and/or mortality. 
 The proportion of abortions ranges from 9-15% of total pregnancies. The 
actual incidence of abortion worldwide is not known but estimates range from 
40-60 million a year of which atleast half are unsafe.1 Nearly 40-50/1000 
women of reproductive age have abortion annually with an abortion ratio of 
260-450/1000 live births. 
 In India, it is estimated that about 6 million abortions take place every 
year of which 2 million are spontaneous and 4 million are induced. Of the 
induced abortions, only about 5 – 6 lakhs are legal and rest are estimated to be 
illegal abortions. 
 Where abortions are legal and statistics are accurate, the mortality ratio 
ranges from 1-3.5 per 1,00,000 abortions in the developed countries. In India, 
the mortality is reported to be 7.8 per 1000 abortions, most of which are illegal. 
 Illegal abortions are a frequent cause of severe short term and long term 
sequelae. 
The most common early complications are: 
1) excessive blood loss 
2) pelvic infection 
3) uterine perforation 
4) cervical injury. 
5) thromboembolism  
6) shock 
7) anaesthetic complications. 
The late sequelae include infertility and ectopic pregnancy. 
Medical termination of pregnancy (MTP) is the voluntary medical or 
surgical removal of a pregnancy before the period of viability. 
 The laws governing the induction of abortion have changed over the 
years and these changes were motivated by a need to  
(i) Eliminate the practice of criminal abortion. 
(ii) To remove unwanted and unplanned pregnancies. 
(iii) To avoid the social and psychological stress associated with the 
birth of an unwanted baby to an unmarried mother. 
(iv) To abolish illegitimate off spring. 
(v) Provide an additional means of family planning and population 
control. 
The MTP act was introduced in India in 1971 as a maternal health 
measure and not a birth control measure;2 and the act was amended in 2002. 
 In spite of availability of safe and effective contraceptive methods, 
couples fail to use them and come for MTP, even in the second trimester, when 
the risks of infection and surgical intervention are high. This tendency is 
particularly high amongst the unmarried and the undecided. Until recently one 
of the best known and highly popular method of II trimester abortion is the 
introduction of bougie – a thick rubber tubing – extra amniotically for the 
induction of abortion. 
 Medical abortion, by virtue of it being simple, safe and effective and 
without the risks of invasive procedures and anaesthesia is becoming the 
method of choice in many centres and has successfully replaced bougie in most 
of the places; the success rate is also as high as 95%.3 
 The introduction of prostaglandin analogues in the late 1970’s changed 
the management of termination of pregnancy in 2nd Trimester. The subsequent 
introduction of antiprogestin, mifepristone, shortened the induction abortion 
interval and reduced the dosage of misoprostol required though the cost of 
Mifepristone and misorpostol combination is still high and is not affordable by 
many in a resource poor setting. 
 Hence there are still places where extra amniotic instillations are being 
practiced and bougie remains a popular method of choice in these places. 
 This study compares the efficacy of misoprostol to the bougie insertion 
in 200 cases who came for second trimester termination of pregnancy at  the 
Institute of Social Obstetrics and Government Kasturba Gandhi Hospital, 
Chennai and approved by hospital ethical  committee 
 The MTP Act 4, 5, 6 
 In India, the medical termination of pregnancy act was passed by the 
parliament in 1971 and came into force on 1st April 1972.  The act liberalized 
the abortion law as a family welfare and health measure to ensure better health 
and prevent risks to the life of women from hazards of criminal abortion. 
Medical termination of pregnancy is permitted under the law up to 20 weeks of 
gestation, but not beyond. 
Grounds for performing MTP: 
 Medical grounds:  when the continuation of pregnancy is likely to 
(i) Endanger the life of the pregnant women. 
(ii) Cause grievous injury to her physical or mental health as in severe 
hypertension, diabetes, cardiac disease, psychiatric illness, genital 
and breast cancer. 
 Eugenic grounds: 
 When there is substantial risk of the child being born with serious 
physical or mental abnormalities. 
-  Hereditary disorders. 
-   Congenital malformation in previous offspring with high risk of 
recurrence. 
-   Rh iso-immunization 
-   Maternal rubella posing risk of anomalies in the fetus. 
Humanitarian grounds: 
            When pregnancy is caused by rape or incest. 
Social grounds: 
              When  
(i) her socio economic status might lead to risk of injury to her health. 
(ii) Pregnancy resulting from failure of contraception- temporary (or) 
permanent method. 
Persons who can perform MTP: 
 The act authorises only a registered medical practitioner having 
experience in obstetrics and Gynecology to perform abortion where the length 
of pregnancy does not exceed 12 weeks; where the pregnancy exceeds  12 
weeks and not more than 20 weeks, the opinion of 2 Registered Medical 
Practitioners is necessary to terminate the pregnancy. 
Qualifications required to do abortion: 
 The doctor is qualified to do MTPs if he/she has one or more of the 
following qualifications. 
(i) if he has assisted a Registered Medical Practitioner in the 
performance of 25 cases of MTP in an approved institution. 
(ii) 6 month of housemanship in obstetrics & gynecology 
(iii) A postgraduate qualification in obstetrics and gynecology. 
(iv) 3 yrs of practice in OBG for those doctors registered before the 
1971 MTP act was passed. 
(v) 1 year of practice in OBG for those doctors registered on or after 
the commencement of the act. 
Place for performing MTP: 
 (i)  A hospital established and maintained by the government. 
 (ii)   A place recognised and approved by the government, under this 
act. 
 The women undergoing MTP should be educated to accept contraception 
but is not mandatory. 
 
Objectives of counselling for MTP: 
- Helping the woman to understand her options regarding the 
pregnancy,  whether to proceed with abortion or not. 
- Informing the woman of the possible risks and possible 
complications. 
- Discussing the likelihood of successful treatment . 
- Discussing future fertility regulation. 
The MTP (amendment) act 2002: 
           The act mainly aims at reducing the rate of unsafe abortions by making 
legal abortion more widely accessible. Lack of access to MTP services at 
primary health care level is an important reason for increased rate of unsafe and 
illegal abortions. The amendment is aiming at decentralization of authority for 
approval and registration of MTP centers from state to district level. 
Methods for induction of abortion according to gestational period: 
Length of Amenorrhea Technique 
<9 weeks Antiprogestins or prostaglandins, Vacuum 
aspiration 
9 – 14 weeks Vacuum aspiration (with cervical preparation 
particularly after 12 weeks and in nulliparous 
woman) 
>14 weeks 1) Antiprogestins + PG  
2) Prostaglandins alone 
3) Hypertonic saline, Urea,   
     Ethacridine lactate 
4) D&E (with cervical preparation) 
 
Methods of 2nd Trimester MTP:7 
Medical methods: 
1. Intra amniotic instillation of drugs: 
 (i) 20% hypertonic saline 
 (ii) Hypertonic glucose 
 (iii) Urea 
 (iv) Prostaglandin 
2. Extra ovular instillation of drugs: 
 (i) 0.1% Ethacridine lactate 
 (ii) Hypertonic saline 
 (iii) Prostaglandins 
 (iv) Mifepristone and Misoprostol 
3. Extra uterine methods: 
 (i) PGF 2 alpha IM 
4. Extra ovular insertion of devices 
 (i) sterile catheters 
 Surgical methods: 
 1) Dilatation and Evacuation 8, 9, 10 
 2) Aspirotomy 
 3) Hysterotomy 
                
Medical  abortion 
 If is the use of drugs for induction of abortion. The introduction of PG 
analogues and mifepristone has changed the management of second trimester 
abortion in the last 2 decades; PG analogues are associated with less side 
effects when compared with oxytocin infusion, hypertonic saline or urea; the 
application of PG analogues for medical abortion is simple does not require 
trained expertise; while surgical abortion 8,9,10 requires. 
(i) Hospital or good clinics for performing the procedure. 
(ii) Anaesthesia. 
(iii) Cervical preparation with misoprostol, mifepristone, laminaria 
tents or mechanical dilatation. 
  and associated with higher chances of  
1) repeated abortions 
2) premature labour 
3) cervical incompetence 
4) secondary infertility 
 The following strategies can be adopted to make medical abortion 
feasible in India; 
1) Continue clinical / acceptability studies; 
This will allow the provider to gain expertise and know that women like 
the method.  
2) Conduct non-clinical studies; 
Qualitative research should document women’s experience and assess 
provider’s knowledge and experience. 
3) Increase provider knowledge; 
Medical abortion training centres should be established or training for 
medical abortion be incorporated in existing surgical MTP training 
courses  and flexibility is to be incorporated in national guidelines to 
facilitate adoption of evidence based regimens. 
4) Increase client knowledge; 
By appropriate media outlets (i.e) women’s magazines, talk/radioshows 
and school health talks. 
5) document serious adverse effects; 
 Serious adverse events should be added to monthly MTP reporting by 
 registered provider. 
 
 Chemical Structure of Misoprostol 
 Naturally occuring PGE1, is not orally sustainable as it is unstable in acid 
media, and also not suitable for parenteral use because of its rapid degradation 
in the blood. 
 Synthetic PGE1, analogue, has been produced by bringing about an 
alteration in the chemical structure of this naturally occuring compound.  The 
chemical formula of misoprostol is C22H38 05 (or) Methyl (13E) – 11, 16- 
Dihydroxy – 16 – Methyl – 9 – OXO – Prost. – 13 – Enoate. 
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MISOPROSTOL 
 Misoprostol is manufactured as 100 and 200 mg. tablet and can be used 
orally, vaginally and rectally.  This drug is very stable in ambient temperature 
and has a long shelf life. 
 Following oral administration this drug absorbed quickly and de-
esterished to be converted into its active pharmacological form misoprostol 
acid. Concentration of this metabolite reaches its peak in plasma by 30 minutes 
and declines rapidly half life 21 minutes)11 
 Primary site of metabolism of this drug is in liver and less than 1 percent 
of this metabolite is excreted in urine. Dose of the drug needs adjustment when 
used in patients with liver disease whereas it is not required in patient with 
renal disease and not on dialysis.12 
 Misoprostol does not affect hepatic mixed function oxidase (cytochrome 
P – 450) enzyme system. 
 Vaginal administration has the advantage of reducing gastrointestinal 
side effects and exerts profound effect on reproductive tract.13 After application 
in the posterior fornix, plasma concentration reaches peak by one to two hour 
and then slowly declines. 
 After oral and vaginal administration of this drug, intrauterine pressure 
begins to increase by 8 and 25 minutes and reached maximum by 25 and  46 
minutes respectively. Maximum uterine contractility was significantly higher 
after vaginal administration.14 
 Cumulative dose upto 2200 mg has been found to be tolerated by 
expectant mothers with no serious side effects when administered over 12 
hours 
 This drug has common adverse effects like nausea, vomiting, diarrhea, 
abdominal pain,chill, shivering and fever which are does dependent.  
Myocardial infarction and bronchospasm has not been reported yet with 
misoprostol.15 
Teratogenicity: 
 Congenital facial paralysis (moebius’ syndrome) and limb defects have 
been reported in infants of women who ingested misoprostal in first trimester in 
an unsuccessful attempt to induce abortion.16  In a recent case control study, 
malformations like transverse limb defects, ring shaped construction of the 
extremities, arthrogryposis, hydrochephalus, holoprosencephaly and exstrophy 
of the bladder has been reported in infants. 
Applications of Misoprostol 
Obstetrics 
1.Cervical Ripening and labour induction. 
2.Labour induction for postdated pregnancy 
3.Labour induction in cases of second and early third trimester termination of 
pregnancies associated with fetal anomalies. 
4.Labour induction in cases of intrauterine fetal death. 
5.Management of spontaneous abortion. 
6.Management of missed abortion. 
7.Medical abortion:alone, or in combination with mifepristone / methotrexate. 
8.Management of cervical pregnancy. 
9.Cervical priming prior to surgical abortion. 
10.Management of uterine atony leading to pospartum haemorrhage. 
Mifepristone or RU-486 
 It is the anti-progestin approved for use in termination of pregnancy. The 
drug helps in two ways 
(i) by causing cervical dilatation and reducing its resistance to 
dilatation. 
(ii) By increasing the sensitivity of uterus to exogenous prostaglandins 
and thus shorten the induction abortion interval, increase the 
successful termination of pregnancy and reduce the total dose of PG 
required.17-20 
Complications associated with medical termination of pregnancy 
Incomplete abortion 
 Patients who underwent medical termination of pregnancy (TOP) were 
more likely to have retained products of conception requiring operative 
intervention. It was as high as 21% in some studies. Though it was less with 
misoprostol, the complication was higher than in patients who had surgical 
abortion (22% versus 4%)21 
 60% of subjects passed the placenta spontaneously within 2hrs, with 
approximately two-thirds of expulsions occurring in the first 30min. Retained 
tissues can lead to hemorrhage and infection. 
Infection : During the 2nd trimester, infection rates for both medical and 
surgical termination of pregnancy remain in the range of 0.4-2%.21, 22 The 
cervix should be cultured for gonorrhea and Chlamydia, ascending genital tract 
infections which are polymicrobial. Routine antibiotic prophylaxis may prevent 
upto half of all infections.23, 24 
Failure of Medical termination of pregnancy: defined as a failure to achieve 
Termination of pregnancy [TOP] in 24-48hrs. 
Uterine rupture: Serious complications including uterine rupture,25, 26 major 
hemorrhage and cervical tear are rare. The incidence of uterine rupture is 0.2% 
in 2nd trimester. Risk factors include previous caesarean delivery, grand 
multipara, advanced gestation, prolonged PG therapy  and use of oxytocin in 
addition to PG’s. 
Live birth:  Second trimester medical TOP with PG analogues has been 
associated with live birth rates of 4% to 10%.27 Physicians should have a 
protocol to induce fetal death before induction. 
Bougie 
 Bougie was once a popular method but with the advent of better methods 
has lost some of its popularity. Still it  is being used in some places, particularly 
in areas where the resources are scarce,  due to its economy, comparatively 
good success rate and minimal complications. 
 This causes expulsion of the fetus by  
i) Causing mechanical irritation of the uterus leading to myometrial 
contraction  
ii) It also separates the membranes from the uterus. 
iii) It causes reflex release of oxytocin. 
iv) There is also release of lysosomal hydrolytic enzymes from the 
decidual cells, which elevate the PG precursor acids such as 
arachidonic acid from membrane phospholipid synthesis. Thus, 
release of PG occurs, resulting  in uterine contractions.   
 Bougie is an inert substance devoid of any systemic complication, and 
being soft and atraumatic it will not damage the cervix or lower segment. 
 
 
REVIEW OF LITERATURE 
- Misoprostol is a PGE1, analogue, produced and used since 1991 by     
Searle, to prevent peptic ulcer disease induced by NSAID’s.11-12 
- Von Euler (1935) found prostaglandin as an abortifacient. 
- The total systemic bioavailability of vaginally administered misoprostol 
in 3 times more than orally administered misoprostol. (Ziemann, Fong. 
S.K., Benowitz NL, Banskter D, Darney PD – 1997).16 
- In a comparative study of oral and vaginal misoprosol in 2nd trimester 
termination, 90% of vaginal group aborted in 48hrs and 69% of oral 
group aborted in 48 hrs (K.S.Wong, C.S.W Ngai, E.L.W. Yeo, L.C.H 
Tang and P.C.Ho, obstetrics and gynaecology 1997). 
- Carbonelle et al – 1999 studied the effect of moistening of misoprostol 
before vaginal application and found it produced no improved efficacy. 
- Acetic acid was used to dissolve misoprostol, to study the effect of 
acidic medium on the efficacy of misoprostol in 2nd trimester and found 
no  improved outcomes. (B. Yilmaz S. kelechi, F.E. Ertas et al; Human 
Reproduction;Nov 1 2005; 20 (11): 3067 – 3071). 
-      Effect of vaginal PH on the efficacy of misoprostol: Vaginal PH does not 
appear to influence the efficacy of intravaginal misoprostol – Patrick ; 
Paul L ;et al (2000) 
-      Misoprostol is uterotonic and provides an effective alternative to other 
methods of midtrimester termination – Del Valle et al 1996. 
- Misoprostol is over 70% effective in terminating pregnancy within 48 
hrs, when used in second trimester – ACOG 2005, Medical management 
of  abortion, ACOG practice bulletin No: 67 ; O & G 106 (4);871-872. 
-      A regimen using a combination of mifepristone 200mg and vaginal 
misoprostol  (600-800 mcg as first dose) and oral misoprostol (400mcg 
every 3hrs for 4 doses) gave the highest complete abortion rate (97%) 
and shortest induction abortion interval (6.5 hrs) Elrafaey et al19 1995 
and Ashok et al, 1999. 
- Cervical ripening – value of intracervical tents in regimens using 
misoprostol is less clear. Jain.JK, Mishell Dr.Jr:- A comparison of 
misoprostol with and without laminaria tents for induction of second 
trimester abortion. Am. J. Obstretrics and Gynaec 1996;  
175:173-177. 
- When mifepristone pretreatment was used before vaginal misoprostol, 
the abortion rate was 90% is 24hrs and induction abortion interval was 9 
hrs – Ho et al;17 1997 – Induction of abortion in the second trimester by 
a combination of mifepristone and misoprostol. 
- In a randomised controlled trial to compare the effectiveness of 6 and 12 
hrly administration of vaginal misoprostol for second trimester 
pregnancy termination Herabutya Y. Chanrachakul B, et.al. 2005 
reported misoprostol (600 mcg) administered at 12 hour intervals was 
associated with fewer adverse effects and was as effective as 6 hour 
interval and there was no significant difference in the mean induction to 
abortion interval at 6 hours (16 hours) and 12 hours (16 hours). 
-      In the study by Snehamay Chaudhuri et al. 2006, the efficacy of 400 
mcg. of tablet misoprostol inserted in the vagina every 12 hours for a 
maximum of 4 doses was compared with extraamniotic ethacridine 
lactate for second trimester MTP. The mean induction to abortion 
interval was shorter in microprostol group (15.5 hours) and rate of 
successful abortion within 48 hours was 95%. 
 
- Women who did not abort within 48hrs (10%) required further 
interventions. either PGE2 vaginal suppositories, PGF2  alpha inj,.D & 
E, oxytocin infusion – John .K, Jain MD, Joh, Kero and Daniel R. 
Mishell, Jr.MD – 1999. 
- Routine antibiotic prophylaxis may prevent up to half of all post – TOP  
infections and is highly cost effective – Sawaya GF, Grady D, 
Kerlihowshik, et al:23 antibiotics at the time of induced abortion. The 
case of universal proplylaxis based on meta analysis. Obstetrics & 
Gynaec 1996; 87:884-890. 
- Jacot F & M, Poulin C, Bilodeau AP, et al28 1993, reported no increase 
in complication rate as compared to 1st trimester abortion, in a 5 year 
experience with second trimester induced abortion. 
-     Retained placenta (incomplete abortion) requiring operative intervention 
was common with misoprostol termination of pregnancy – 22% than 
with  surgical method of termination. Textbook – High risk pregnancy – 
 Management options: D.K. James; P. J.Steer. 
- The use of misoprostol in 2nd trimester abortion in women with prior 
caesarean delivery was not associated with an excess of complications 
compared with women with unscarred uteri – Jan.  E. Dickinson.M.D- 
ACOG 2005;105:352-356. 
- Chen. M, Shih. JL, Chin. WT, Hsieh. FJ; reported separation of 
caesarean scar during 2nd trimester intravaginal misoprostol abortion; 
obstetrics &  Gynaec 1999-94-840. 
- There is good conception rates postabortally with use of misoprostol       
C.Reinun MD 1999. 
-  Boorn and Gustive29 in 1974 studied & found that myometrial activity 
can be initiated by mechanical stimulation of uterus. 
- Extra ovular placement of rubber tube was advocated by George (1979) 
for midtrimester abortion with prolonged IA interval being the major   
problem. 
-    Midtrimester abortion was induced with No12 rubber catheter; 96% 
aborted  within 40 hours: Dr. Rajan & Dr. K.R. Usha 1979. 
- Extra ovular rubber catheter for midtrimester, abortion was used with 
success by Gaurad 1979.  
- Saxena S.C. and Sharma30 1980 have studied termination of pregnancy 
using rubber catheter and Ryle’s tube in 70 cases with 86.9% success 
rate. 
- In a study of 200 cases between 14-22 weeks, midtrimester              
abortion was induced using rubber catheter and success rate of 90% has 
been reported by J. Mishra and Rita Kumari 1981. 
- There has been a resurgence in catheter based techniques and                     
they are found to be effective for cervical ripening. Shuman D.J., 
Frenkel . E, Tovbin. J et al31. Ripening of the unfavourable cervix with 
extra amniotic catheter; Clinical experience a review. obstet and Gynaec 
survey 1996; 51; 621-627. 
- Anitha Singh and Shanthi Roy32 1985 in their study of 75 patients 
using rubber catheter for 2nd trimester abortion, reported a success rate of 
92%. 
AIM OF THE STUDY 
 To compare the relative efficacy of vaginal misoprostol and extra 
amniotic bougie in second trimester abortion and to compare the 
(i) Induction abortion interval 
(ii) Complete abortion rate and  
(iii) Success rate between the two methods. 
MATERIALS AND METHODS 
 The study was conducted at Institute of social obstetrics – Government 
Kasturba Government Gandhi Hospital, Chennai, in the family welfare 
department. 100 women who came for second trimester abortion were 
randomized to receive 400 mcg of misoprostol every 12 hours for a maximum 
of 4 doses and another 100 patients were subjected to termination by extra 
amniotic Bougie insertion. 
Inclusion Criteria: 
- 14 – 20  weeks of Pregnancy  
- Women fulfilling indications for MTP according to MTP act. 
- No other medical/surgical complications 
Exclusion Criteria: 
- History of previous uterine surgery (i.e) myomectomy or 
Caesarean section     
-   Uncontrolled seizure disorder  
-   Cardio vascular disease  
-   Glaucoma 
-   Pulmonary, hepatic or renal disorders 
-  Allergy to misoprostol or other prostaglandins 
 
Patient assessment 
         This includes history, physical examination, appropriate laboratory 
studies and counselling. 
History:  
- Menstrual history & last menstrual period 
- Past reproductive history, sexual history 
- Prior pelvic surgery and any known uterine anomalies. 
- Current medical illness, medications and allergies  
Physical examination :  
- Vital signs, weight, height and cardio pulmonary status was recorded 
in every patient   
-  Speculum examination was done to rule out local cervical pathology 
-  Bimanual examination was done to assess the uterine size 
 LABORATORY STUDIES: The following were done in all patients 
- Complete Haemogram 
- Blood grouping and typing 
- urine analysis 
- Screening for common sexually transmitted disease – TV, Moniliasis 
, HIV & VDRL 
- Blood sugar, urea,  
- ECG and anaesthetic fitness were obtained for patients who opted for 
permanent family planning measures with the MTP. 
- Ultrasound was done in all cases for accurate determination of 
gestational age, placental location and presence of uterine anomalies. 
-  Inj T.T. and prophylactic antibiotics were given for all patients. 
          The patient was informed about the medication, abortion and the need for 
an operative intervention – D & C, in case of incomplete abortion was 
explained and a written consent was obtained.  Risks of hemorrhage, 
hysterotomy, fever, vomiting  and diarrhea associated with misoprostol were 
also addressed. 
Method of misoprostol induction: 
 Under aseptic precautions, 400 mcg of misoprostol  was kept in the 
posterior fornix. Further doses are withheld if there are uterine contractions or 
bleeding. Patients were observed in semi ICU & the following were noted. 
 
- Time of induction  
- 4th hrly Temp, PR & BP 
- Time of onset of contractions,  rupture of membranes, bleeding  
- Time of expulsion 
- Time of repeat doses. 
- Nature of abortion – complete / Incomplete  
- Oxytocics needed 
- D&C required for completion of abortion 
- Maternal Complications – fever, pain, & vomiting were noted. 
 10U of oxytocin in 500 ml of RL and methyl ergometrine 0.2 mg iv was 
given to all patients after expulsion to prevent excessive bleeding. 
 In cases of incomplete abortion, the remaining products were removed 
manually or by curettage. Such of those who did not expel after 48 hours, were 
given high titre oxytocin or laminaria tent with oxytocin or PGE2 gel with 
oxytocin (ie. after 48 hrs-no uterine contraction, bleeding or the os is closed) 
- USG was done for all patients before discharge  
 
Bougie insertion:- 
 After ensuring  the patient’s bladder is empty,  the patient in put in 
lithotomy position. Under aseptic precautions, Bougie was introduced 
extraamniotically. No anaesthesia was required. It was followed 24 hrs later by 
oxytocin infusion. 
The patients were observed in semi ICU & the following were noted: 
- The onset of uterine contractions, pain or vaginal bleeding. 
- Time of expulsion. 
- Nature of abortion/complete or incomplete. 
 10 U Oxytocin in 500ml of RL and 0.2mg iv methyl ergometrine were 
given to all patients to prevent excessive bleeding. 
- In cases of incomplete abortion the products were removed by  
D& C. 
- Patients who failed to expel after 48hrs were treated with either 
PGE2 gel intracervically or  laminaria tent and high titre oxytocin. 
- USG was done for all patients before discharge  
 In both methods of termination of pregnancy, patients who failed to 
expel with other methods also were taken for hysterotomy. 
ANALYSIS OF STUDY 
 This is a randomized trial comparing the efficacy of intravaginal  
misoprostol to extra amniotic bougie insertion in  second trimester  MTP 
conducted at Institute of social obstetrics, Government Kasturba Gandhi 
hospital, Chennai during the period March 2006 – August 2007 
100 patients received 400mcg of vaginal misoprostol every 12 hours up 
to a maximum of 4 doses 
100 patients were subjected to termination of pregnancy by extra 
amniotic insertion of bougie. The results were subjected to statistical analysis 
using the Chi – square test.  
Age distribution:- (Table -1) 
Age in 
Yrs. 
Misoprostol 
regimen 
(n-100) 
Bougie insertion 
(n=100) 
 
No of 
Patients 
% No of Patients % 
16-20 16 16% 4 4% 
21-25 29 29% 32 32% 
26-30 46 46% 49 49% 
31-35 9 9% 15 15% 
Both the groups were age matched to the extent possible though we  
preferred using misoprostol in the age group 16-20, since most of them were 
unmarried or  primi. 
Parity  distribution:-  
Parity Misoprostol regimen (n-100) Bougie insertion (n=100) 
 No of Patients % No of Patients % 
Nullipara 16 16% 5 5% 
G-2 50 50% 56 56% 
G-3 34 34% 31 31% 
G-4 -- -- 8 8% 
Out of the 21 nullipara, 16 were subjected to  misoprostol regimen, while 
in 8 patients who were gravida 4 and more, the pregnancy was terminated by 
extra amniotic bougie. More than 50% of the patients  who came for second 
trimester termination were second gravida. 
 
 
 
 
Distribution according to Gestational Age 
Table -3 
Gestational age in  
weeks 
Misoprostol regimen 
(n-100) 
Extra amniotic Bougie 
(n=100) 
 No of Patients % No of Patients % 
14-16 46 46% 10 10% 
17-18 42 42% 57 57% 
19-20 12 12% 33 33% 
Indications for MTP 
Table : 4 
Indications for MTP No. of  Patients % 
Unmarried Pregnancy 21 10.5% 
Unwanted Pregnancy 86 43% 
Limiting  the Family 60 30% 
Failure of Sterilisation 4 2% 
Medical Reasons 10 5% 
Eugenic 2 1% 
Others 17 8.5% 
Most Common indication for MTP was unwanted pregnancies (43%) 
Unmarried  Pregnancies accounted for 10.5% in this study 
MTP for  pregnancies from failure of Sterlisation was done in 2% 
 Total dose of Misoprostol required for abortion 
Table : 5 
Primi Multi Total Total dose 
of 
Misoprostol 
(mcg) 
No. % No. % No. % 
400 6 37.5% 29 34.52% 35 35% 
800 8 50% 32 38.09% 40 40% 
1200 2 12.5% 11 13.09% 13 13% 
1600 - - 11 13.09% 11 11% 
 
- 35 out of 100 patients expelled with a single dose of misoprostol. 
- of the remaining, 40 patients expelled with 2 doses of misoprostol. 
- 11 patients required maximum of 4 doses. 
- 14 of 16 nullipara, expelled with 2 doses. 
 Comparison of Induction abortion interval between the  
groups in primi 
Table: 6 
 
- while 87.5% in the misoprostol group expelled in less than 24 hrs; all the 
patients in bougie group expelled after 24 hrs, the difference is statistically 
significant. ( p value 0.001) 
Misoprostol 
regimen (n=16) 
Bougie  insertion 
(n=5) 
 
Induction 
abortion 
interval in 
hrs 
No of 
pts 
% 
No of 
pts 
% 
 
<12 
12 - 24 
24 - 48 
>48 
6 
8 
2 
- 
37.5% 
50% 
12.5% 
 
- 
- 
5 
- 
- 
- 
100% 
- 
 
x2 – 13.1 
p value 
0.001 
Comparison of Induction abortion interval between the  
groups in multi 
Table: 7 
 
- w
h
i
l
e
 
7
2
.61% of multi in the misoprostol regimen expelled in less than 24 hrs, 
77.88% of multi in the bougie group expelled between 24 – 48 hrs, with 
a statistically significant difference. 
- 1 in  the misoprostol regimen and 3 in the bougie group; who failed to 
expel even with other methods were taken for hysterotomy. 
Misoprostol 
(n=84) 
regimen 
Bougie (n=95) 
insertion 
 
Induction 
abortion 
interval in 
hrs 
No of 
pts 
% 
No of 
pts 
% 
<12 
12 - 24 
24 - 48 
>48 
29 
32 
18 
4 
34.52%
38.09%
21.42%
4.76% 
2 
16 
56 
18 
2.10% 
16.84% 
58.94% 
18.94% 
 
x2 – 56.9 
p value 
0.00 
 
Comparison  of the  Average induction abortion interval  
between the groups 
Table : 8 
Total no. of 
patients 
Average IA 
Interval (hrs) 
 
IA 
interval 
(hrs) 
Mode of 
Termination 
Primi Multi Primi multi 
<24 hrs Misoprostol 14 61 13.76 13 
 Bougie - 18 - 21.07 
24-48 
hrs 
Misoprostol 2 18 25.65 23.47 
 
Bougie 5 56 36.12 36.50 
Primi 
x2-13.1  
p 0.00 
Multi  
x2-42.8 
p value 
0.00 
- In patients who expel within  24 hrs in the misoprostol group, the 
average IA interval in Primi is 13.76 hrs; and 13 hrs in  multi 
- For patients who expel between 24-48 hrs, the average IA interval in 
misoprostol group is 25.65 hrs and 23.47 hrs in Primi and Multi 
respectively, while in the bougie group it is 36.12 hrs and 36.50 hrs in 
primi and multi respectively 
Comparison  of the nature  of abortion between the groups 
 Table: 9 
5 patients  in the Misoprostol group & 21 patients in the bougie group, had 
to have additional methods like high titre oxytocin, laminaria tent, PGE2  gel 
or  hysterotomy since they did not expel even up to 48 hrs of 
bougie/1600mcg of misoprostol  
 
 
Complete 
abortion 
Incomplete 
abortion 
  
Mode of 
termination  No of 
Patients 
% 
No of 
Patients
% 
Misoprostol 
regimen 
 
Extra 
amniotic 
Bougie 
79 
 
 
52 
79% 
 
 
52% 
16 
 
 
27 
16% 
 
 
27% 
 
x2  6.3 
p value 
0.01 
Comparison of success rate between the groups 
Table: 10 
Mode of 
termination 
Success 
rate 
Failure 
rate 
 
Misoprostol 
regimen 
95 
 
5 
 
Extra amniotic 
bougie 
76 21 
x2-11.3 
p value 
0.001 
Thus misoprostol has statistically significant abortion rate at 48 hrs over the 
bougie method of termination. 
Success and failure rate in relation to parity with  
misoprostol regimen 
Table : 11 
Parity 
Total no of 
pts 
Successful 
abortion 
Failure 
Success 
rate 
Failure 
rate 
Primi 16 16 - 100% - 
G2 50 47 3 94% 6% 
G3 34 32 2 94.12% 5.88% 
• Criteria for failure were when expulsion did not occur within 48 hrs 
of insertion of bougie or with 1600mcg of misoprostol. 
• In 4 women, expulsion resulted following high titre oxytocin infusion 
• In 1 woman, hysterotomy was done when additional measures like 
high titre oxytocin failed. 
Success and failure rate in relation to parity with  
extra amniotic bougie 
Table : 12 
parity 
Total no 
of pts 
Successful 
abortion 
Failure 
Success 
rate 
Failure 
rate 
Primi 5 5 - 100% - 
2 56 44 12 78.57% 21.42% 
3 31 24 7 77.42% 22.58% 
4 and > 8 6 2 75% 25% 
Comparing the groups, in gravida 2  
                                  x2-5.2;   p value 0.02, 
                          Gravida 3: x2-4.2;  p value 0.04. 
- 18 of the 21 failure cases expelled with other methods 
- 8 with high titre oxytocin infusion 
- 6 with PGE2 gel and oxytocin infusion 
- 4 with laminaria  tent and oxytocin infusion 
- 3 patients who failed to respond to alternative methods were taken for 
hysterotomy. 
Comparison of success and failure rate in relation to gestational age 
Table : 13 
GA in 
weeks 
Method of 
termination 
No. 
of pts
Successful 
abortion 
Failure
Success 
rate 
Failure 
rate 
Misoprostol 46 46 - 100% - 14-16 
Bougie 10 8 2 80% 20% 
Misoprostol 42 38 4 90.48% 9.52% 17-18 
Bougie 57 44 13 77.20% 22.80%
Misoprostol 12 11 1 91.66% 8.34% 19-20 
Bougie 33 27 6 81.82% 18.18%
 
Result comparing the groups in relation to Gestational Age 
Table : 14 
GA in weeks x2 value p value 
14-16 9.5 0.002 
17-18 3.0 0.08 
19-20 0.65 0.42 
The success rate at 14-16, 17-18 and 19-20wks, were 100%; 90.48% and 
91.66% respectively with misoprostol regimen, while they were only 80%; 
77.20% and 81.82% respectively with bougie; though the difference is 
statistically significant only at 14-16wks. 
Complications with misoprostol regimen. 
Table : 15 
Complication No of patients % 
Pain 22 22% 
Fever 9 9% 
Vomiting 7 7% 
Blood transfusion - - 
The most common side effects noted with misoprostol were 
(i) crampy lower abdominal pain 
(ii) vomiting 
Complications with extra amniotic bougie 
Table : 16 
 
Complication No of pts % 
Fever and other signs of 
sepsis 
5 5% 
Bleeding requiring 
transfusion 
- - 
- 5 patients developed fever and foul smelling vaginal discharge and were 
treated with higher antibiotics. 
- Blood transfusion was not necessary for any of the patients in either of 
the groups. 
 
 
 
 DISCUSSION 
This is a randomized trial comparing the efficacy of Intravaginal 
misoprostol to the extra amniotic bougie insertion with100 patients in each 
group who sought MTP at Institute of Social Obstetrics and Government  
Kasturba Gandhi hospital , Chennai . 
The results of this study are discussed as follows: 
In the study by John.K.Jain et al33 comparing the efficacy of 200mcg of 
misoprostol every 6 or every 12hrs; the mean age was 28.4 years. In this study 
the average age was 28yrs(TABLE-1)  
The mean parity in this study was 2.6; and this is comparable to the 
study by Daniel.R..Mishell, John.K.Jain33 where the mean parity was 
2.8.(Table-2) 
Most common indication for MTP in this study was unwanted 
pregnancies. 
TERMINATION WITH MISOPROSTOL Misoprostol has many 
advantages over other PGs. It is less expensive and does not require 
refrigeration for storage as with Gemeprost. Though misoprostol is being 
widely used in I trimester MTP with or without mifepristone as a standard 
operative protocol, there is no such protocol for use of misoprostol in second 
trimester MTP. 
Various dosage regimens are being tried with varied success. 
Dose Dosage Interval  
400mcg 12th hrly In this study 
400mcg 12th hrly Snehamay chaudhari et al34, 2007 
400mcg 12th hrly Herabutya y, Punyavachira et al 2003 
400mcg 6th hrly K.S. Wong; C.S.W.Ngai et al35 2000 
400mcg 6th hrly G.Novab, M.N.Helw 1998 
400mcg Every 3 hrs for a 
maximum of 5 doses
k.S.Wong; C.S.W.Ngai; P.C.Ho35-2000 
600mcg 12th hrly Herabutya Y Chanrachakul et al 2000 
200mcg 12th hrly Herabutya Y; Chanrachakul et al 2000 
200mcg 6th hrly/ 12th hrly John.K.Jain,M.D,John Kuo and Daniel 
R.Mishell JR M.D33-1999 
 
In this study, the average induction abortion interval for all gestational 
age is 18.17 Hrs. 
This is comparable to the result in various studies for all gestational 
ages. 
Dose Average  
IA 
Interval 
 
400mcg 12th hrly 15.5hrs Snehamay chaudhari et al34, 2007 
400mcg 12th hrly 16hrs Herabutya y, Punyavachira et al36 2005 
200mcg 12th hrly 14hrs John.K.Jain,M.D,John Kuo and Daniel 
R.Mishell JR M.D33-1999 
600mcg 12th hrly 24.1hrs Herabutya Y; Chanrachakul 2000 
200mcg 12th hrly 27.5hrs Tong Sung et al 1997 
400mcg 12th hrly 16.9hrs G.Novab, M.N.E.L. Helw et al 1998 
In this study, 75% of the patients expelled with less than 800mcg; Most 
of the primi (87.5%) expelled with an average dose of 628.5mcg and most of 
the multi (72.61%) expelled with an average dose of 609.8mcg. This is in 
comparison to the study by Snehamay chaudhari et al34 2007, using 400mcg of 
intravaginal misoprostol every 12 hrs, with the average dose of 760mcg of 
misoprostol.  
The maximum dose in this study was 1600mcg which was required in 11 
women; comparatively similar average dose of 2000mcg was used in the study 
By C.S.W.Ngai et al35 2000; and also showed that up to 4000mcg over 48hrs 
was well tolerated. 
While the complete abortion rate in this study is 79%,  the same in  
various studies are as follows. 
Dose 
Complete 
Abortion 
Rate 
Study 
200mcg 12th hrly 80% Srisomboon J; Tongsung.T et al 1997 
200mcg 12th hrly 
400mcg 12th hrly 
600mcg12th hrly 
65% 
72% 
78% 
Herabutya Y ; Chanrachakul et al 1998 
400mcg 6th hrly 85% G.Novab; M.N.E.L.Helw et al1998 
400mcg 3rd hrly 80% Wong.K.S;Ngai.N.S et al35 1998 
200mcg6th hrly 83% Herabutya.Y; Punyavachira et al 1997 
MTP was considered successful when there was complete evacuation of 
the pregnancy in 48 hrs. it was noted in 95% in this study. The success rates in 
various studies are as follows 
Dose Success 
Rate 
Study 
400mcg 12th hrly 82% Herabutya et al; 1998 
600mcg 12th hrly 92% Herabutya et al36; 2005 
400mcg 12th hrly 95% Snehamay chaudhari et al34; 2006 
600mcg 12th hrly 90% Herabutya et al 1998 
200mcg 12th hrly 92% Nuutila et al37; 1997 
200mcg 12th hrly 89% Jain and Mishell et al33; 1999 
MTP was considered a failure, if expulsion did not occur with in 48 hrs; 
of the 5 patients who failed to expel in our study; 4 patients expelled with high 
titres oxytocin and in 1 patient who did not expel even with other methods, 
hysterotomy was resorted to. The success rate at 14-16 wks, 17-18 weeks, 19-
20weeks were 100%; 90.48% & 91.66% respectively comparable to that in the 
study by Snehamay Chaudhari et al34 2006 where in the success rates were 
100%; 88.88% 83.33% at 14-16; 17-18, 19-20 weeks respectively. 
Analgesia was required in 22% of women who had abdominal pain in 
this study, whereas in other studies, the complication rates were higher.  
- 49% in the study by John .K. Jain et al33 1999 
- 36.5% in the study By K.S.Wong; C.S.W.Ngai et al35 2000. 
- Fever was seen in 9% of patients similar to that reported by 
John.K.Jain et al33 1999 where it was 8% 
- Vomiting was reported in 15% of patients by Snehamay Chaudhari 
et al34 2006%; but in this study it was only 7%.  
- In this study no women required blood transfusion and in other 
studies by K.S.Wong; C.S.W.Ngai et al35 2000; John.K.Jain, John 
Kuo et al33 1999; Snehamay chaudhari et al34 2006, the blood loss 
was less than 500ml and no women required blood transfusions. 
 
 
 
 TERMINATION BY EXTRA AMNIOTIC BOUGIE: 
- With this method, only 18% expelled in less than 24hrs with an 
average induction abortion interval of 21.07hrs, while 61% 
expelled between 24-48 hrs, with an average induction  abortion 
interval of 36.12hrs in primi and 36.50hrs in multi . 
- The success rate in 48hrs is 79% in this study. Saxena.S.C. and 
Sharma.S30 in 1980 have showed a success rate of 86.9% with 
rubber catheter 
- In this study, 5% of the patients had fever with signs of sepsis and 
this is similar to 5.8% infection rate reported by Saxena.S.C and 
Sharma.S30 in 1980 
Though medical abortion has largely replaced bougie, there is still a 
place for extra amniotic bougie particularly in resource poor settings where the 
affordability of medical abortion is low. However, bougie should be considered 
only as a last measure when other techniques are available. The limited use of 
this once very popular technique has resulted in paucity of authentic studies in 
the recent past. 
SUMMARY 
- The average age was 28 years and the mean parity in this study was 
2.8 
- Most common indication for MTP in this study was unwanted 
pregnancies 
- There is a statistically significant difference in the induction 
abortion interval between the misoprostol and bougie groups in 
both primi [p.value-0.001] and multi(p value -0.00) 
- Similarly the abortion rate at 24hrs was also found to be 
statistically significant in both primi(0.00) and multi [o.oo] 
- The abortion rate was 75% in 24hrs in the misoprostol group 
whereas it was only 18% in the bougie group. 
- The difference between these methods with regards to the success 
rate was also found to be statistically significant (0.01) being 95% 
with misoprostol regimen. Where as it was 79% with extra 
amniotic bougie. 
- The difference between the methods as regards the completion of 
abortion was also statistically significant (p value 0.01) being 79% 
with misoprostol regimen, whereas it was only 52% with extra 
amniotic bougie 
- The success rate at 14-16 weeks with misoprostol was 100% 
whereas it was 80% with bougie, the difference is statistically 
significant (p value-0.02); the difference at other gestational age 
was not statistically significant 
- The out come was not influenced by parity 
 
                           
 
 
 
 
 
CONCLUSION 
   This study comparing the efficacy of 400mcg of intravaginal 
misoprostol every 12 hrs to the extra amniotic bougie in second trimester MTP 
conducted at Institute of social obstetrics, Government Kasturba Gandhi 
Hospital Chennai, 400mcg intravaginal misoprostol every 12 hrs has a better 
out come in terms of 
(i) Shortened induction abortion interval 
(ii) Increased abortion rate at 24 hrs 
(iii) High success rate 
(iv) Increased complete abortion rate  
Overall misoprostol 400mcg has been found to be a safe, efficacious and 
an affordable method of second trimester MTP 
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 PROFORMA 
S. No 
NAME:         AGE:           IPNO:          OCCUPATION: 
SOCIOECONOMIC STATUS:            EDUCATIONAL STATUS: 
MARITAL STATUS: 
MARRIED/UNMARRIED/DIVORCEE/WIDOW/DESERTED  
GRAVIDA:              PARA:                LIVE:             ABORTION: 
M/H:                           LMP:                         LCB: 
GA: 
INDICATION FOR TERMINATION: 
PREVIOUS OBSTETRIC HISTORY: 
RELEVANT MEDICAL/SURGICAL HISTORY: 
PAST HISTORY 
GENERAL EXAMINAION:- 
PR:       BP:             ANAEMIA:              PEDAL OEDEMA; 
CVS      HT:  WT:   THYROID    
RS: 
OBSTETRIC EXAMINATION: 
PER ABDOMEN: UTERINE SIZE 
FP 
SPECULUM EXAMINATION:- 
PER VAGINAL EXAMINATION: 
INVESTIGATION: 
COMPLETE HAEMOGRAM 
URINE: ALBUMIN, SUGAR, DEPOSTS 
BLOOD GROUPING AND TYPING 
VDRL, HIV (AFTER GETTING CONSENT FROM THE ABORTION 
SEEKER) 
SMEAR : TV, MONLIASIS 
BLOOD SUGAR:  
UREA: 
ECG 
USG 
Mode of Termination: 
Misoprostol 
Initial Dose 
Number of doses repeated 
Time of onset of contractions 
Bleeding or rupture of membranes 
Nature of abortion 
Time of expulsion 
Induction abortion interval 
Mode of termination-vaginal/Hysterotomy 
Oxytocics needed 
D and C  
Maternal Complications  
Extra Amniotic bougie insertion 
- Time of insertion of bougie 
- Time of onset of contractions, 
- Bleeding or rupture of membranes 
- Time of expulsion 
- Induction abortion interval 
- Mode of termination-Vaginal / Hysterotomy 
- Oxytocics needed  
- D and C     
- Maternal complications 
 
 
